AR

Abhishek Ramnarayan Pathak

Active Director Director DIN 11074376
DIN 11074376 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhishek Ramnarayan Pathak

Data last updated:

Abhishek Ramnarayan Pathak is a Director at Moonrise Remedy Care Private Limited (since 2025). The company operates in Pharma.

DIN 11074376
Primary Designation Director
Industry Pharma
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Moonrise Remedy Care Private Limited U21003GJ2025PTC162086
Director24 Apr 20252025Active

Board colleagues of Abhishek Ramnarayan Pathak

NameDINCompanyDesignation
Manish Ramnarayan Pathak11074377Moonrise Remedy Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Moonrise Remedy Care Private Limited
Premium access

Shareholding and investment profile for Abhishek Ramnarayan Pathak

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Ramnarayan Pathak

Abhishek Ramnarayan Pathak currently holds 1 directorship: Moonrise Remedy Care Private Limited (Director, since 24 Apr 2025).

Abhishek Ramnarayan Pathak was first appointed on 24 Apr 2025 as Director at Moonrise Remedy Care Private Limited.

The current boards of Abhishek Ramnarayan Pathak's companies include Manish Ramnarayan Pathak (Moonrise Remedy Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available